Raynaud’s Phenomenon in the Feet: Causes & Treatment

Medically reviewed by Dr. Tom Biernacki, DPM

Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Township, MI
Last reviewed: May 2026

Quick answer: Raynaud Foot can significantly impact your daily life and mobility. Our Michigan podiatrists provide expert evaluation and evidence-based treatment — from conservative care to minimally invasive procedures — to relieve your symptoms and restore function. Same-day appointments available in Howell and Bloomfield Township, MI.

Raynaud Foot - Michigan podiatrist, Balance Foot & Ankle
Raynaud Foot treatment | Balance Foot & Ankle, Michigan

Raynaud’s phenomenon affecting the foot causes episodic vasospasm of the digital arteries in the toes — triggered by cold exposure or emotional stress — producing a characteristic triphasic color change: pallor (white) as vasospasm cuts off blood flow, followed by cyanosis (blue) as deoxygenated blood stagnates in the digits, followed by erythema (red) and pain as vasospasm resolves and blood rushes back. Raynaud’s is far more common in the hands but frequently affects the feet simultaneously or alone. Primary Raynaud’s (Raynaud’s disease) occurs without an underlying condition, predominantly in young women, and is benign. Secondary Raynaud’s (Raynaud’s syndrome) is triggered by an underlying disease — most importantly systemic sclerosis (scleroderma), lupus, mixed connective tissue disease, and rheumatoid arthritis — and can progress to digital ischemia and tissue loss if the underlying condition is untreated.

Primary vs. Secondary Raynaud’s: Critical Distinction

Feature Primary Raynaud’s Secondary Raynaud’s
Underlying cause None — idiopathic vasospasm Systemic sclerosis (most common); lupus (SLE); mixed CTD; rheumatoid arthritis; Sjögren’s; vasculitis; medications (beta-blockers, ergotamines, chemotherapy)
Onset Young women (teens to 30s); family history common Any age; onset after 30 in women or any age in men increases secondary suspicion
Severity Mild to moderate; symmetric; no tissue damage More severe; asymmetric possible; digital ulcers; gangrene risk in scleroderma
Nailfold capillaries Normal on capillaroscopy Abnormal — dilated, distorted capillary loops; loss of capillary density (scleroderma pattern)
ANA (antinuclear antibody) Negative or low titer Positive in most secondary causes; specific antibodies (anti-Scl-70, anti-centromere for scleroderma; anti-dsDNA for lupus)
Prognosis Benign; rarely progresses to secondary Determined by underlying disease; scleroderma carries risk of digital amputation without treatment
Treatment escalation Lifestyle measures usually sufficient; calcium channel blockers if needed Underlying disease treatment essential; more aggressive vasodilator therapy; bosentan (endothelin antagonist) for scleroderma-related digital ulcers

Managing Raynaud’s Attacks: Immediate and Preventive

For acute vasospasm attacks affecting the feet: move to a warm environment immediately; warm the entire body (not just the feet) — putting hands in warm water or under the arms activates systemic warming more effectively than local foot rewarming alone; wool or insulated socks and insulated footwear; avoid rubbing the toes aggressively during pallor phase (can damage ischemic tissue). Prevention focuses on cold avoidance: battery-heated insoles or socks for outdoor cold-weather activity; wool socks year-round; avoiding air conditioning extremes; hand warmers in shoes during cold months. Stress management reduces emotionally-triggered attacks. Smoking cessation is mandatory — nicotine is a potent vasoconstrictor that dramatically worsens Raynaud’s attacks and increases digital ischemia risk.

Medical Treatment of Raynaud’s Affecting the Feet

Treatment Indication Mechanism Evidence
Calcium channel blockers (nifedipine, amlodipine) First-line pharmacotherapy; both primary and secondary Vasodilation of digital arteries; reduces attack frequency and severity Strong — reduces attack frequency 30–40% in RCTs
Phosphodiesterase-5 inhibitors (sildenafil, tadalafil) Secondary Raynaud’s refractory to CCBs; digital ulcers cGMP-mediated vasodilation; endothelial protection Strong for secondary; especially effective in scleroderma
Topical nitrates (glyceryl trinitrate patch at wrist) Adjunct; for localized vasodilation Nitric oxide-mediated vasodilation Moderate evidence; headache side effect limits use
Bosentan (endothelin receptor antagonist) Scleroderma-related digital ulcers specifically Blocks ET-1 vasoconstriction; reduces new digital ulcer formation Approved for digital ulcer prevention in scleroderma
Digital sympathectomy Severe refractory Raynaud’s with recurrent ulcers and tissue loss risk Surgical removal of sympathetic nerve fibers around digital vessels 70–80% response; for severe cases only

Raynaud’s Foot Evaluation at Balance Foot & Ankle

We evaluate Raynaud’s phenomenon affecting the feet at our Howell (4330 E Grand River Ave) and Bloomfield Township (43494 Woodward Ave #208) offices, with ABI and toe pressure measurements, ANA screening, and coordination with rheumatology when secondary Raynaud’s is suspected. Call (810) 206-1402 for an evaluation of cold-sensitive color-changing toes.

PubMed: Raynaud’s Phenomenon Foot Symptoms

Ready to Get Relief?

Same-day appointments available in Howell & Bloomfield Township, MI

4.9★ | 1,123 Reviews | 3,000+ Surgeries

Or call: (810) 206-1402

Doctor Answer

What is Raynaud’s phenomenon in the feet and how is it managed?

Raynaud’s phenomenon causes episodic vasospasm in response to cold or stress, causing the toes to turn white (pallor), then blue (cyanosis), then red (reactive hyperemia) as blood flow is cut off and restored. Primary Raynaud’s is not associated with other disease; secondary Raynaud’s accompanies connective tissue diseases like scleroderma or lupus. Management includes avoiding cold triggers, wearing warm socks and insulated footwear, and calcium channel blockers or vasodilators for moderate to severe cases. Secondary causes require systemic management.

Balance Foot & Ankle surgeons are affiliated with Trinity Health Michigan, Corewell Health, and Henry Ford Health — three of Michigan’s largest health systems.